23. Brenton L. Saunders, Allergan (Formerly Actavis)
2014 Compensation: $36,613,829
Overpaid By: $20,689,611
Saunders has served as chief executive of Allergan since 2014. Shares are off 1 percent over the past year, and Saunders has faced criticism for his approach to the pharma business, which relies on dealmaking more than inventing new drugs.
